Vivani Medical, Inc. (VANI)
USD 0.99
(-0.01%)
USD 0.99
(-0.01%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 45.79 Million USD | -10.43% |
| 2022 | 51.13 Million USD | 837.65% |
| 2021 | 5.45 Million USD | 4.52% |
| 2020 | 5.21 Million USD | -68.57% |
| 2019 | 16.59 Million USD | 55.39% |
| 2018 | 10.68 Million USD | -26.32% |
| 2017 | 14.49 Million USD | -13.77% |
| 2016 | 16.81 Million USD | -40.49% |
| 2015 | 28.25 Million USD | -34.41% |
| 2014 | 43.06 Million USD | 239.84% |
| 2013 | 12.67 Million USD | 58.56% |
| 2012 | 7.99 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 53.78 Million USD | 17.45% |
| 2024 Q2 | 48.22 Million USD | -10.34% |
| 2023 Q1 | 44.58 Million USD | -12.81% |
| 2023 Q3 | 53.31 Million USD | -10.55% |
| 2023 Q2 | 59.6 Million USD | 33.71% |
| 2023 Q4 | 45.79 Million USD | -14.11% |
| 2023 FY | 45.79 Million USD | -10.43% |
| 2022 Q2 | 6.41 Million USD | -36.09% |
| 2022 Q4 | 51.13 Million USD | -10.33% |
| 2022 FY | 51.13 Million USD | 837.65% |
| 2022 Q1 | 10.04 Million USD | 84.12% |
| 2022 Q3 | 57.02 Million USD | 788.61% |
| 2021 Q4 | 5.45 Million USD | -92.59% |
| 2021 Q3 | 73.63 Million USD | -3.01% |
| 2021 Q2 | 75.91 Million USD | 169.73% |
| 2021 FY | 5.45 Million USD | 4.52% |
| 2021 Q1 | 28.14 Million USD | 531.05% |
| 2020 Q3 | 3.52 Million USD | -26.7% |
| 2020 FY | 5.21 Million USD | -68.57% |
| 2020 Q1 | 3.9 Million USD | -76.48% |
| 2020 Q4 | 4.46 Million USD | 26.63% |
| 2020 Q2 | 4.8 Million USD | 23.08% |
| 2019 Q3 | 23.89 Million USD | -24.18% |
| 2019 FY | 16.59 Million USD | 55.39% |
| 2019 Q4 | 16.59 Million USD | -30.54% |
| 2019 Q2 | 31.52 Million USD | -18.23% |
| 2019 Q1 | 38.54 Million USD | 260.87% |
| 2018 Q4 | 10.68 Million USD | -6.46% |
| 2018 FY | 10.68 Million USD | -26.32% |
| 2018 Q2 | 13.61 Million USD | 30.84% |
| 2018 Q1 | 10.4 Million USD | -28.21% |
| 2018 Q3 | 11.42 Million USD | -16.13% |
| 2017 Q2 | 24.26 Million USD | -19.44% |
| 2017 Q3 | 19.08 Million USD | -21.37% |
| 2017 Q4 | 14.49 Million USD | -24.02% |
| 2017 FY | 14.49 Million USD | -13.77% |
| 2017 Q1 | 30.12 Million USD | 79.19% |
| 2016 FY | 16.81 Million USD | -40.49% |
| 2016 Q4 | 16.81 Million USD | -36.0% |
| 2016 Q3 | 26.26 Million USD | -23.02% |
| 2016 Q2 | 34.12 Million USD | 51.25% |
| 2016 Q1 | 22.55 Million USD | -20.13% |
| 2015 Q4 | 28.24 Million USD | -15.15% |
| 2015 Q2 | 36.94 Million USD | -6.38% |
| 2015 Q1 | 39.45 Million USD | -8.39% |
| 2015 Q3 | 33.28 Million USD | -9.89% |
| 2015 FY | 28.25 Million USD | -34.41% |
| 2014 Q2 | 12.11 Million USD | 25.07% |
| 2014 FY | 43.06 Million USD | 239.84% |
| 2014 Q4 | 43.06 Million USD | 350.33% |
| 2014 Q3 | 9.56 Million USD | -21.04% |
| 2014 Q1 | 9.68 Million USD | -23.58% |
| 2013 FY | 12.67 Million USD | 58.56% |
| 2013 Q4 | 12.67 Million USD | 0.0% |
| 2012 FY | 7.99 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -46.008% |
| BrainsWay Ltd. | 62.97 Million USD | 27.274% |
| Cerus Corporation | 197.74 Million USD | 76.841% |
| Envoy Medical, Inc. | 7.64 Million USD | -499.437% |
| electroCore, Inc. | 16.38 Million USD | -179.472% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -495.385% |
| IceCure Medical Ltd | 16.41 Million USD | -179.08% |
| Inogen, Inc. | 326.19 Million USD | 85.96% |
| OrthoPediatrics Corp. | 449.58 Million USD | 89.814% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -67.939% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -176.235% |
| MaxCyte, Inc. | 268.27 Million USD | 82.929% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -465.583% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1160.96% |
| Orthofix Medical Inc. | 925.31 Million USD | 95.051% |
| PAVmed Inc | 33.11 Million USD | -38.28% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 68.075% |
| RxSight, Inc. | 182.55 Million USD | 74.913% |
| Sight Sciences, Inc. | 166.65 Million USD | 72.519% |
| SI-BONE, Inc. | 230.42 Million USD | 80.125% |
| TELA Bio, Inc. | 78.04 Million USD | 41.322% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 81.82% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -326.813% |
| Acutus Medical, Inc. | 53.96 Million USD | 15.128% |
| Talis Biomedical Corporation | 98.34 Million USD | 53.43% |
| Spectral AI, Inc. | 10.69 Million USD | -328.33% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 79.054% |
| CVRx, Inc. | 115.22 Million USD | 60.256% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 21.929% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1370.089% |
| Bioventus Inc. | 810.91 Million USD | 94.352% |
| Venus Concept Inc. | 93.65 Million USD | 51.1% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -78.025% |
| LivaNova PLC | 2.42 Billion USD | 98.115% |
| 908 Devices Inc. | 202.98 Million USD | 77.438% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 94.312% |
| Nemaura Medical Inc. | 14.56 Million USD | -214.47% |
| NeuroPace, Inc. | 107.65 Million USD | 57.458% |
| LENSAR, Inc. | 69.58 Million USD | 34.186% |
| Apyx Medical Corporation | 79.24 Million USD | 42.205% |
| Cutera, Inc. | 346.29 Million USD | 86.775% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -8.999% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2447.108% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 83.078% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -7.351% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.789% |
| Axonics, Inc. | 719.92 Million USD | 93.639% |
| Outset Medical, Inc. | 313.8 Million USD | 85.406% |
| IRIDEX Corporation | 34.43 Million USD | -32.992% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 88.684% |
| IRadimed Corporation | 92.15 Million USD | 50.305% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -771.66% |
| INVO Bioscience, Inc. | 20.88 Million USD | -119.253% |
| Telesis Bio, Inc. | 70.41 Million USD | 34.958% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 70.281% |
| Varex Imaging Corporation | 1.24 Billion USD | 96.335% |
| Quipt Home Medical Corp. | 247.4 Million USD | 81.489% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -391.912% |
| Pulmonx Corporation | 178.95 Million USD | 74.408% |
| Dynatronics Corporation | 25.94 Million USD | -76.546% |
| Modular Medical, Inc. | 13.8 Million USD | -231.694% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -326.932% |
| Semler Scientific, Inc. | 78.06 Million USD | 41.335% |
| InMode Ltd. | 863.28 Million USD | 94.695% |
| Bruker Corporation | 4.24 Billion USD | 98.922% |
| Cytosorbents Corporation | 53.26 Million USD | 14.013% |
| DexCom, Inc. | 6.26 Billion USD | 99.269% |
| Align Technology, Inc. | 6.08 Billion USD | 99.247% |
| Viveve Medical, Inc. | 25.91 Million USD | -76.734% |
| ZimVie Inc. | 1.2 Billion USD | 96.201% |
| Movano Inc. | 9.42 Million USD | -386.116% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 90.798% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1160.96% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 21.929% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 95.193% |
| Profound Medical Corp. | 43.68 Million USD | -4.831% |
| Insulet Corporation | 2.58 Billion USD | 98.231% |
| enVVeno Medical Corporation | 48.63 Million USD | 5.835% |
| Surmodics, Inc. | 185.73 Million USD | 75.343% |
| iCAD, Inc. | 41.41 Million USD | -10.573% |
| Nuwellis, Inc. | 9.77 Million USD | -368.751% |
| Biotricity, Inc. | 5.94 Million USD | -670.653% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 89.427% |
| Aethlon Medical, Inc. | 8.24 Million USD | -455.386% |
| InspireMD, Inc. | 47.64 Million USD | 3.875% |
| PAVmed Inc. | 33.11 Million USD | -38.28% |
| BIOLASE, Inc. | 35.1 Million USD | -30.472% |
| Beyond Air, Inc. | 56.96 Million USD | 19.599% |
| FONAR Corporation | 214.24 Million USD | 78.624% |
| AxoGen, Inc. | 196.82 Million USD | 76.732% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 83.727% |
| Inari Medical, Inc. | 674.23 Million USD | 93.208% |
| UFP Technologies, Inc. | 404.13 Million USD | 88.668% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -95.726% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -381.916% |
| Tenon Medical, Inc. | 6.34 Million USD | -621.781% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -386.84% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 55.815% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.009% |
| Sintx Technologies, Inc. | 15.36 Million USD | -198.061% |
| NanoVibronix, Inc. | 6.67 Million USD | -586.2% |
| Quanterix Corporation | 425.01 Million USD | 89.225% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -391.912% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 14.76% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 97.377% |
| TransMedics Group, Inc. | 706.04 Million USD | 93.514% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 27.527% |
| NeuroMetrix, Inc. | 21.42 Million USD | -113.761% |
| Hyperfine, Inc. | 94.19 Million USD | 51.383% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 82.952% |
| Biomerica, Inc. | 9.25 Million USD | -394.889% |
| Bone Biologics Corporation | 3.73 Million USD | -1125.252% |
| AVITA Medical, Inc. | 144.33 Million USD | 68.271% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -840.674% |
| Silk Road Medical, Inc | 265.3 Million USD | 82.738% |